ArticleImmunology1993
Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor V beta 3 transgenic mice.
Article in Immunology, 1993. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 46 citations in OpenAlex.
- Characterization of genetic humanized mice with transgenic HLA DP401 or DRA but deficient in endogenous murine MHC class II genes upon Staphylococcus aureus pneumonia.Animal models and experimental medicine · 2023Article
- Tumor-targeted superantigens produce curative tumor immunity with induction of memory and demonstrated antigen spreading.Journal of translational medicine · 2023Article
- Temperate Bacteriophages-The Powerful Indirect Modulators of Eukaryotic Cells and Immune Functions.Viruses · 2021Review
- Two common structural motifs for TCR recognition by staphylococcal enterotoxins.Scientific reports · 2016Article
- Superantigens subvert the neutrophil response to promote abscess formation and enhance Staphylococcus aureus survival in vivo.Infection and immunity · 2014Article
- Intranasal exposure to bacterial superantigens induces airway inflammation in HLA class II transgenic mice.Infection and immunity · 2006Article
- Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent.The Journal of experimental medicine · 2004Article
- Staphylococcal enterotoxin H contrasts closely related enterotoxins in species reactivity.Immunology · 2002Article
- Therapy of human non-small-cell lung carcinoma using antibody targeting of a modified superantigen.British journal of cancer · 2001Article
- Intratumoral IL-18 gene transfer improves therapeutic efficacy of antibody-targeted superantigen in established murine melanoma.Gene therapy · 2001Article
- A role for perforin in downregulating T-cell responses during chronic viral infection.Journal of virology · 1999Article
- T cell- and perforin-dependent depletion of B cells in vivo by staphylococcal enterotoxin A.Immunology · 1998Article
- Tumor therapy with an antibody-targeted superantigen generates a dichotomy between local and systemic immune responses.The American journal of pathology · 1997Article
- Genetically engineered superantigens as tolerable antitumor agents.Proceedings of the National Academy of Sciences of the United States of America · 1997Article
- Prevention of superantigen-induced down-regulation of T-cell mediated cytotoxic activity by IL-2 in vivo.Immunology · 1997Article
- In vivo anergized CD4+ T cells express perturbed AP-1 and NF-kappa B transcription factors.Proceedings of the National Academy of Sciences of the United States of America · 1996Article
- Genetically engineered superantigens in experimental tumor therapy.Springer seminars in immunopathology · 1996Review
- Overexpression of the T-cell receptor V beta 3 in transgenic mice increases mortality during infection by enterotoxin A-producing Staphylococcus aureus.Infection and immunity · 1995Article
- Antibody-targeted superantigens are potent inducers of tumor-infiltrating T lymphocytes in vivo.Proceedings of the National Academy of Sciences of the United States of America · 1995Article
- Enhanced and prolonged efficacy of superantigen-induced cytotoxic T lymphocyte activity by interleukin-2 in vivo.Cancer immunology, immunotherapy : CII · 1995Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The response of mouse T cells to the superantigen staphylococcal enterotoxin A (SEA) requires 1000-fold higher concentrations compared to human T cells. In order to develop a sensitive model for SEA studies in mice, the immunopharmacology has been studied in T-cell receptor (TcR) V beta 3 transgenic (TGV beta 3) and non-transgenic (non-TG) C57Bl/6 mice. The frequency of SEA-responsive T cells in the TGV beta 3 mice exceeded 90%, whereas a 10-fold lower frequency was seen in normal C57Bl/6 mice. Nanograms of SEA injected intravenously into TGV beta 3 mice induced strong cytolytic T lymphocyte (CTL) activity against SEA-coated major histocompatibility complex (MHC) class II+ B-lymphoma cells, whereas administration of 1000-fold higher amounts of SEA to non-TG littermates or normal C57Bl/6 mice induced only a moderate response. Kinetic analysis demonstrated that the CTL activity was more rapidly detectable in TG mice, but substantial levels were seen 2 days after SEA injection in both TGV beta 3 and non-TG mice. The cytotoxic T-cell response induced by SEA in TGV beta 3 and non-TG mice was completely MHC class II dependent, as SEA-coated MHC class II-transfected syngeneic B16 melanoma cells but not untransfected B16 cells were sensitive to lysis. Large amounts of tumour necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) accumulated in serum of TGV beta 3 mice after injection of 10 ng SEA, whereas only marginal amounts were recorded in non-TG even after injection of 100 micrograms SEA. Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis demonstrated that SEA-induced TNF-alpha and IFN-gamma mRNA reached maximal levels 1 hr after SEA administration in TGV beta 3 mice, whereas peak serum levels of TNF-alpha and IFN-gamma proteins were recorded after 2 hr. Comparison of the mRNA levels of a panel of cytokines in the TGV beta 3 and non-TG mice revealed that almost similar amounts of interleukin-1 (IL-1) were induced in both strains, whereas IL-4 was only detected at significant levels in the TGV beta 3 mouse. The results suggest that TGV beta 3 mice are suitable for studying in vivo immune responses to superantigens at concentrations comparable to the potent effects elicited in humans. Moreover, this model is useful for detailed studies on the dynamic regulation of T-cell activation and anergy induced by superantigens.
Indexed as
Identifiers
7691731PMC1421909W2183332343What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.